Predicting the global clamour for coronavirus vaccines - even as early as six months ago, when several candidates were still in late-stage clinical trials - could not have been "rocket science", AIIMS chief Dr Randeep Guleria told NDTV Friday night, as the centre responded to Serum Institute CEO Adar Poonawalla's admission about existing production facilities being "very stressed".